Edwin Zhang
Stock Analyst at HC Wainwright & Co.
(0.19)
# 3,263
Out of 4,415 analysts
8
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:
5 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CALT Calliditas Therapeutics AB (publ) | Reiterates: Buy | $50 | $19.00 | +163.13% | 4 | Oct 16, 2023 | |
| RPHM Reneo Pharmaceuticals | Initiates: Buy | $28 | $1.74 | +1,509.20% | 1 | Dec 21, 2021 | |
| RARE Ultragenyx Pharmaceutical | Initiates: Buy | n/a | $43.20 | - | 1 | Sep 30, 2021 | |
| FGEN FibroGen | Downgrades: Neutral | n/a | $1.13 | - | 1 | Apr 7, 2021 | |
| ALDX Aldeyra Therapeutics | Initiates: Buy | n/a | $4.21 | - | 1 | Feb 8, 2021 |
Calliditas Therapeutics AB (publ)
Oct 16, 2023
Reiterates: Buy
Price Target: $50
Current: $19.00
Upside: +163.13%
Reneo Pharmaceuticals
Dec 21, 2021
Initiates: Buy
Price Target: $28
Current: $1.74
Upside: +1,509.20%
Ultragenyx Pharmaceutical
Sep 30, 2021
Initiates: Buy
Price Target: n/a
Current: $43.20
Upside: -
FibroGen
Apr 7, 2021
Downgrades: Neutral
Price Target: n/a
Current: $1.13
Upside: -
Aldeyra Therapeutics
Feb 8, 2021
Initiates: Buy
Price Target: n/a
Current: $4.21
Upside: -